---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-26-040525"
form_type: "8-K"
ticker: "JANL"
cik: "0001133062"
company_name: "JANEL CORP"
filed_at: "2026-10-22T21:00:27+00:00"
generated_at: "2026-10-22T21:02:08.241650+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Janel acquires EnCor Biotechnology for $17M; $11.96M cash plus $5.04M subordinated note

## Summary
- On Oct. 20, 2026, Janel's Antibodies Incorporated bought 100% of Gainesville, Florida-based EnCor Biotechnology, an antibody/reagent maker for neurological disease research.
- Base purchase price $17.0M: $11.96M cash at closing plus $5.04M subordinated promissory note; sellers include Gerry Shaw, University of Florida Research Foundation and employee shareholders.
- Deferred payments to Shaw of $1.68M each on the first, second and third anniversaries; first payment subject to working-capital adjustment versus $250,000 target.
- On Oct. 16, 2026, lenders increased the acquisition facility by $15M; $11M was funded at closing, and EnCor joined as a borrower.
- Janel is seeking SEC relief from Rule 3-05 audited EnCor financials, arguing they are not material; no historical or pro forma statements were filed yet.

## SEC filing metadata
- accession: 0001140361-26-040525
- form_type: 8-K
- ticker: JANL
- cik: 0001133062
- company_name: JANEL CORP
- filed_at: 2026-10-22T21:00:27+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 2.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1133062/000114036126040525/0001140361-26-040525-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1133062/000114036126040525/ef20084224_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-26-040525
- JSON: https://secwatch.observer/filing/0001140361-26-040525.json
- Plain text: https://secwatch.observer/filing/0001140361-26-040525.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.